Evaluation of VX-659/TEZ/IVA in Cystic Fibrosis Subjects 6 Through 11 Years of Age
Clinical trial NCT03633526 · TERMINATED
Trial details
- NCT number
- NCT03633526
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-03
- Primary completion
- 2019-01-18
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.